Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

2.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA; Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators..

JAMA. 2004 Jan 21;291(3):309-16.

PMID:
14734593
4.
5.
6.
7.

An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.

Bernink PJ, de Weerd P, ten CF, Remme WJ, Barth J, Enthoven R, Haagen FD, Holwerda NJ, Klomps HC.

J Cardiovasc Pharmacol. 1991;17 Suppl 1:S53-6.

PMID:
16296711
8.

Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.

Dunselman PH, van Kempen LH, Bouwens LH, Holwerda KJ, Herweijer AH, Bernink PJ.

Am J Cardiol. 1998 Jan 15;81(2):128-32.

PMID:
9591892
9.

Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.

Cocco G, Rousseau MF, Bouvy T, Cheron P, Williams G, Detry JM, Pouleur H.

J Cardiovasc Pharmacol. 1992 Jul;20(1):131-8.

PMID:
1383622
10.

Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.

Rousseau MF, Pouleur H, Cocco G, Wolff AA.

Am J Cardiol. 2005 Feb 1;95(3):311-6.

PMID:
15670536
11.

A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.

Klein W, Mitrovic V, Neuss H, Schlepper M, Cocco G, Prager G, Fitscha P, Meisner W.

J Cardiovasc Pharmacol. 1991;17 Suppl 1:S50-2.

PMID:
16296710
12.

Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.

Deanfield JE, Detry JM, Sellier P, Lichtlen PR, Thaulow E, Bultas J, Brennan C, Young ST, Beckerman B; CAPE II Trial Investigators..

J Am Coll Cardiol. 2002 Sep 4;40(5):917-25.

13.
15.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators..

J Am Coll Cardiol. 2006 Aug 1;48(3):566-75.

16.

Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).

de Vries RJ, van den Heuvel AF, Lok DJ, Claessens RJ, Bernink PJ, Pasteuning WH, Kingma JH, Dunselman PH.

Int J Cardiol. 1996 Dec 6;57(2):143-50.

PMID:
9013266
17.

Ivabradine: new drug. Best avoided in stable angina.

[No authors listed]

Prescrire Int. 2007 Apr;16(88):53-6.

PMID:
17458043
18.

Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.

Pehrsson SK, Ringqvist I, Ekdahl S, Karlson BW, Ulvenstam G, Persson S.

Clin Cardiol. 2000 Oct;23(10):763-70.

19.

Usefulness of amlodipine for angina pectoris.

Taylor SH.

Am J Cardiol. 1994 Jan 27;73(3):28A-33A. Review.

PMID:
8310973
20.
Items per page

Supplemental Content

Support Center